Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin

Eva Hellström-Lindberg(Karolinska Institutet), Åke Öst(Synlab Czech (Czechia)), Lena Kanter‐Lewensohn(Karolinska University Hospital)

Leukemia Research

May 1, 1997

10.1016/s0145-2126(96)00110-5

Cited by 118

Related Papers

Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.

|PubMed|1991|765

Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis

|Acta Paediatrica|1991|449

Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

|British Journal of Haematology|1997|314

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

|Blood|1998|306

Colonoscopic surveillance in long-standing total ulcerative colitis—A 15-year follow-up study

|Gastroenterology|1990|197